Castle Biosciences (NASDAQ:CSTL) rallied more than 20% after delivering a strong Q3 performance. When analyzed through the lens of the Adhishthana Principles, the stock shows clear signs of momentum building. Here's why the current setup looks promising and what lies ahead.Castle Biosciences and Its Weekly ChartAccording to the Adhishthana Principles, stocks typically form a Cakra structure between Phases 4–8. This structure, often resembling a channel with an arc, generally carries bullish implications. Th ...